← Back to Clinical Trials
Recruiting NCT06065930

NCT06065930 Adaptive Mechanisms In GRown up ObeSity Study (AMIGROS)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06065930
Status Recruiting
Phase
Sponsor Vastra Gotaland Region
Condition Obesity
Study Type OBSERVATIONAL
Enrollment 45 participants
Start Date 2023-05-05
Primary Completion 2025-12-31

Trial Parameters

Condition Obesity
Sponsor Vastra Gotaland Region
Study Type OBSERVATIONAL
Phase N/A
Enrollment 45
Sex ALL
Min Age 40 Years
Max Age 70 Years
Start Date 2023-05-05
Completion 2025-12-31
Interventions
Subcutaneous microdialysis

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The investigator recently showed that the glycan-binding adipokine galectin-1 increased during overfeeding and that galectin-1 independently could predict type 2 diabetes. Further, the molecules that induce insulin release in the fasting state when blood glucose is normal remain elusive. It is possible that galectin-1 is involved in adaptive mechanisms in adipose tissue in obese subjects.

Eligibility Criteria

Inclusion Criteria: 1. Men and women of age: 40.0 - 70.0 years 2. BMI: 18.0 - 25.0 kg/m2 (lean subjects) and BMI 30.0 - 38.0 kg/m2 (Ob-IS and Ob-IR) 3. Fasting insulin \< 9.0 mU/l (lean and Ob-IS subjects) and fasting insulin \> 9.0 mU/l (Ob-IR) 4. Fasting glucose \< 6.1 mmol/l 5. Body temperature \< 37.5°C 6. First-degree relative with known T2D in Ob-IR 7. Weight stable ± 5 kg \< 3 months before screening 8. Fluent in Swedish and can follow given instructions 9. Consent given to participate Exclusion Criteria: 10. First-degree relative with known T2D in lean or Ob-IS subjects 11. Alcohol intake \> 10 units/week or known high alcohol intake \< 10 years back in time 12. Daily use of cigarettes or daily frequent use of smokeless tobacco not enabling the participant to suspend nicotine during a visit at the research center without getting abstinent 13. Regular physical activity corresponding to Saltin-Gimby level 4 14. Special diet eg Atkins or 5:2 for weight reduction. Vegetarian food a

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology